New COVID-19 study links nurses’ mental health to quality of care

Stories of stress and burnout among healthcare workers, particularly nurses, continue to make news during the COVID-19 pandemic and new research shows these mental health problems can  decreased quality of patient care provided to patients.

The study, published recently in the journal Healthcare,[1] found more severe the mental health symptoms reported by nurses, the more likely they will rate the quality of care in their work units in hospitals, long-term care homes and community health centers as poor.

The study used data from two surveys of nurses working in B.C. conducted in a partnership between UBC nursing researchers and the B.C. Nurses Union. The first survey was completed in December 2019 and involved 5,512 nurses, and the second survey was done in June 2020 and attracted 4,523 nurses. Nurses were asked to assess their anxiety, depression, PTSD and burnout, ranging from none to mild, moderate or severe. They were also asked to rate the overall safety of their primary unit, on a scale ranging from “failing” to “excellent”, to rate the general quality of nursing care they delivered to patients with options ranging from “poor” to “excellent”, and to state how likely they would recommend their unit to friends and family for care, on a scale ranging from “definitely no” to “definitely yes”.

"Nurses rated quality of care during the pandemic lower compared to the pre-pandemic period—something that likely reflects their heavier workloads during the pandemic," explained lead author Farinaz Havaei, RN, PhD, assistant professor, School of Nursing, University of British Columbia, Canada. "In fact, one study of Canadian nurses showed that nurses reported walking longer distances to work during COVID-19, as well as increased mental workloads, and more instances of missed patient care."

Havaei said what is even more troubling is that the more significant their mental health symptoms, the lower their ratings of quality and safety—both before and during the pandemic. For example, when nurses reported high emotional exhaustion, their ratings of quality and safety of patient care delivery dropped eightfold, she explained.

"For us, this highlights how closely linked nurses’ health and patients’ health really is," Havaei said.

Recommendations to improve the mental health status of nurses under COVID

"Our findings show that lower mental health among nurses is associated with lower ratings of quality of care and safety, and vice versa. These findings also support longstanding issues in the nursing workforce that have been reported for decades and worsened by the pandemic," Havaei said. Providing safe, quality patient care is impossible without a healthy nursing workforce. 

She said hospitals should pay close attention to work environment factors such as heavy workloads and inadequate staffing, which are known risk factors to nurses’ mental health.

Her team of researchers also recommends that nurses’ mental health should be included as part of a comprehensive set of quality indicators in hospitals, tracked over time and publicly reported in an aggregated format. Patients and members of the public can then use the information to identify high-performing healthcare organizations.

"Nurse have been on the front lines of our COVID-19 response for more than two years now. We urgently need to protect their mental health for their wellbeing and that of the communities that they serve," Havaei said.

The study was co-authored by Dr. Peter Smith, president and senior scientist at the Institute for Work & Health in Toronto; Dr. Sheila Boamah, assistant professor of nursing at McMaster University; and UBC students Xuyan Tang and Caroline Frankfurter.

Find more news on the impact of COVID on healthcare


Reference: 

1. Farinaz Havaei, Xuyan Tang, Peter Smith, et al. The Association between Mental Health Symptoms and Quality and Safety of Patient Care before and during COVID-19 among Canadian Nurses.  Healthcare. Vol 10, Issue 2. 10.3390/healthcare10020314.

Around the web

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel. 

Kit Crancer, RBMA board member, speaks with Radiology Business about key legislative developments on the Hill that will affect the specialty.